236 related articles for article (PubMed ID: 31403963)
1. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
2. Opioid-induced esophageal dysfunction.
Snyder DL; Vela MF
Curr Opin Gastroenterol; 2020 Jul; 36(4):344-350. PubMed ID: 32427604
[TBL] [Abstract][Full Text] [Related]
3. Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.
Ratuapli SK; Crowell MD; DiBaise JK; Vela MF; Ramirez FC; Burdick GE; Lacy BE; Murray JA
Am J Gastroenterol; 2015 Jul; 110(7):979-84. PubMed ID: 26032150
[TBL] [Abstract][Full Text] [Related]
4. Impact of opioids on esophageal motility.
Snyder DL; Vela MF
Neurogastroenterol Motil; 2023 May; 35(5):e14587. PubMed ID: 37060333
[TBL] [Abstract][Full Text] [Related]
5. Opioid-Induced Esophageal Dysmotility (OIED) - A Case Report.
Halasz V; Knittel L; Fox MR
Z Gastroenterol; 2023 Sep; 61(9):1221-1224. PubMed ID: 36516950
[TBL] [Abstract][Full Text] [Related]
6. Incidence of opioid-induced esophageal dysfunction.
Ladrón Abia P; Ortiz V; García-Campos M; Saéz-González E; Mínguez Sabater A; Izquierdo R; Garrigues V
Gastroenterol Hepatol; 2023 Apr; 46(4):249-254. PubMed ID: 35605820
[TBL] [Abstract][Full Text] [Related]
7. Opioid-induced esophageal dysfunction - Prevalence and manometric findings.
Alcalá-González LG; Jiménez-Masip A; Relea Pérez L; Barber-Caselles C; Barba-Orozco E
Rev Esp Enferm Dig; 2022 Jan; 114(1):16-21. PubMed ID: 33486967
[TBL] [Abstract][Full Text] [Related]
8. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
[TBL] [Abstract][Full Text] [Related]
9. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain.
Palangio M; Wideman GL; Keffer M; Landau CJ; Morris E; Doyle RT; Jiang JG; Damask M; de Padova A
Clin Ther; 2000 May; 22(5):600-12. PubMed ID: 10868557
[TBL] [Abstract][Full Text] [Related]
10. Chronic opioid use is associated with obstructive and spastic disorders in the esophagus.
Sanchez MJ; Olivier S; Gediklioglu F; Almeida M; Gaeta M; Nigro M; de la Rosa R; Nguyen M; Lalehzari M; Regala F; Njei B; Deng Y; Ciarleglio M; Masoud A
Neurogastroenterol Motil; 2022 Mar; 34(3):e14233. PubMed ID: 34532898
[TBL] [Abstract][Full Text] [Related]
11. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
12. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Curr Med Res Opin; 2022 Nov; 38(11):1947-1957. PubMed ID: 36000252
[TBL] [Abstract][Full Text] [Related]
13. Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia.
Quader F; Mauro A; Savarino E; Tolone S; de Bortoli N; Franchina M; Ghisa M; Edelman K; Jha LK; Penagini R; Gyawali CP
Neurogastroenterol Motil; 2019 Sep; 31(9):e13678. PubMed ID: 31310444
[TBL] [Abstract][Full Text] [Related]
14. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
Zacny JP; Gutierrez S
Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
[TBL] [Abstract][Full Text] [Related]
15. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Clin J Pain; 2023 Mar; 39(3):107-118. PubMed ID: 36728675
[TBL] [Abstract][Full Text] [Related]
16. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
[TBL] [Abstract][Full Text] [Related]
17. Chronic opioid users with dysphagia are indistinguishable from symptomatic nonusers on functional lumen imaging probe evaluation.
Patel D; Khodadadi A; Jadcherla A; Rengarajan A; Rogers BD; Gyawali CP
Neurogastroenterol Motil; 2023 May; 35(5):e14519. PubMed ID: 36578248
[TBL] [Abstract][Full Text] [Related]
18. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Pain Med; 2024 Mar; 25(3):173-186. PubMed ID: 38243702
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety of tramadol and other opioids following total hip and knee arthroplasty.
Bosco E; Riester MR; Beaudoin FL; Schoenfeld AJ; Gravenstein S; Mor V; Zullo AR
BMC Geriatr; 2024 Apr; 24(1):319. PubMed ID: 38580920
[TBL] [Abstract][Full Text] [Related]
20. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis.
Babaei A; Szabo A; Shad S; Massey BT
Neurogastroenterol Motil; 2019 Jul; 31(7):e13601. PubMed ID: 30993800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
